Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hogy Medical CoTSE:3593 47 EBIT per Share is 円56.57 as of Dec. 2025. GuruFocus rates TSE:3593 with a GF Score™ of 47/100 and a GF Value™ of 円4,422.15 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 686 Medical Devices & Instruments companies, Hogy Medical Co ranks worse than 72.01% on this metric.
Hogy Medical Co's EBIT per Share for the
three
months ended in Dec. 2025 was 円35.34.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円56.57.
During the past 12 months, the average EBIT per Share Growth Rate of Hogy Medical Co was -33.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -7.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -0.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -2.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Hogy Medical Co's EBIT per Share or its related term are showing as below:
TSE:3593'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.8 Med: 1.65 Max: 15.9
Current: -7.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Hogy Medical Co was 15.90% per year. The lowest was -19.80% per year. And the median was 1.65% per year.
TSE:3593's 3-Year EBIT Growth Rate is ranked worse than 72.01% of 686
companies
in the Medical Devices & Instruments industry
Industry Median: 9.25
vs TSE:3593: -7.40
Hogy Medical Co's EBIT for the
three
months ended in Dec. 2025 was 円762 Mil.
Hogy Medical Co (TSE:3593) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Hogy Medical Co EBIT per Share Related Terms
Hogy Medical Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Hogy Medical Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円56.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hogy Medical Co (TSE:3593) has a EBIT per Share of 円56.57 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hogy Medical Co and its competitors. According to the industry distribution chart, Hogy Medical Co ranks #494 out of 686 companies in the Medical Devices & Instruments industry, placing it in the top 72%.
Is Hogy Medical Co's EBIT per Share too high?
Hogy Medical Co's current EBIT per Share is 円56.57. Based on the distribution chart, Hogy Medical Co ranks #494 out of 686 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Hogy Medical Co has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hogy Medical Co ranks #494 out of 686 companies for EBIT per Share. This places Hogy Medical Co in the lower half of its industry. The industry median EBIT per Share is 9.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.25, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hogy Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hogy Medical Co's current EBIT per Share is 円56.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Hogy Medical Co (TSE:3593) is currently considered Significantly Overvalued. The stock's GF Value™ is 円4,422.15, compared to a current price of 円6,660.00 — trading 50.6% above its estimated fair value. The current EBIT per Share is 円56.57. Hogy Medical Co's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Hogy Medical Co (TSE:3593), the current EBIT per Share is 円56.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hogy Medical Co (TSE:3593) Overvalued in 2026?
Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued.
The current stock price of 円6,660.00 is trading 50.6% above its estimated GF Value™ of 円4,422.15.
GuruFocus considers Hogy Medical Co to be Significantly Overvalued.
Key valuation signals for TSE:3593:
EBIT per Share: 円56.57
GF Value™: 円4,422.15 vs. price of 円6,660.00 (50.6% above fair value)
No single metric tells the full story. See the TSE:3593 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
47GF Score
Get the complete analysis for TSE:3593
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3593 has been successfully added to your 
